Company profile: OMNY Health
1.1 - Company Overview
Company description
- Provider of a healthcare data sharing and research platform connecting providers and life sciences to improve patient care and drive innovation; real-world data solutions with comprehensive patient data; operational and clinical decision-making tools; custom data and dashboards; medical device insights; and social determinants of health datasets.
Products and services
- Data Sharing and Research Platform: Enterprise-grade platform that connects healthcare providers and life sciences companies to exchange healthcare data, advancing collaborative research, improving patient care, and driving innovation
- Operational and Clinical Decision-Making Tools: Analytics-driven tools supplying healthcare providers with data and insights to bolster operational efficiency and inform clinical decision-making
- Real-World Data Solutions: Research-grade access to comprehensive patient data across diverse care settings to support life sciences research and development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OMNY Health
Laetus
HQ: Germany
Website
- Description: Provider of inline quality control and track & trace systems, including serialization, aggregation, and traceability, plus packaging execution systems and vision inspection solutions (ARGUS, POLYPHEM, INSPECT) to ensure packaging accuracy, product integrity verification, supply chain transparency, counterfeit protection, recall efficiency, and efficient returns.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Laetus company profile →
Medrio
HQ: United States
Website
- Description: Provider of advanced electronic data capture (EDC) and e-clinical tools for complex clinical trials, offering real-time data access via dynamic reports, exports, and automated casebooks; supply chain optimization for coordinated dispensing aligned with manufacturing, packaging, labeling, and logistics; participant comprehension and engagement solutions; services to accelerate study timelines and improve clinical data integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medrio company profile →
Belong Life
HQ: United States
Website
- Description: Provider of a free patient navigation app and disease-specific social networks for cancer and multiple sclerosis, enabling patients, caregivers, and healthcare professionals to connect and manage care. Solutions include a conversational AI cancer mentor, an AI clinical trials matching assistant, and a platform for healthcare organizations to create and manage online patient communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Belong Life company profile →
Ontoforce
HQ: Belgium
Website
- Description: Provider of DISQOVER, an ontology-based semantic data and knowledge platform for life sciences. It unlocks hidden insights to accelerate research and drug development, with modules for R&D (target identification, drug screening, lead optimization), Clinical (trial design, clinical insights), Regulatory (compliance, medical affairs, pre-market insights), and Cross-Functional Intelligence (competitive intelligence, internal knowledge).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ontoforce company profile →
Deep Genomics
HQ: Canada
Website
- Description: Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OMNY Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OMNY Health
2.2 - Growth funds investing in similar companies to OMNY Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OMNY Health
4.2 - Public trading comparable groups for OMNY Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →